LBX Pharmacy Chain JSC
SSE:603883
P/FCFE
Price to FCFE
Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | P/FCFE | ||||
---|---|---|---|---|---|
CN |
LBX Pharmacy Chain JSC
SSE:603883
|
21.1B CNY | 11.7 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
74.6B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.9B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.7B USD | -2.7 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
46.8B BRL | 306 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
46.5B CNY | 9.6 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
929.8B JPY | 20.4 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.3B SAR | 31.5 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
77.3B MXN | 40.4 | ||
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
560B JPY | 86.8 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
25.6B CNY | 12.7 |
P/FCFE Forward Multiples
Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.